Embla Medical hf.
OSSFF
$4.15
-$0.15-3.49%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.04% | 18.30% | 4.82% | 47.20% | -4.15% |
| Total Depreciation and Amortization | 73.29% | 14.53% | 8.07% | -6.67% | 28.69% |
| Total Amortization of Deferred Charges | -76.67% | -- | -- | -- | -0.24% |
| Total Other Non-Cash Items | -299.46% | 332.06% | 71.80% | 119.22% | 158.70% |
| Change in Net Operating Assets | 317.17% | -30.86% | -140.48% | 8.70% | -62.92% |
| Cash from Operations | 20.11% | 11.12% | -22.06% | 242.03% | 14.07% |
| Capital Expenditure | -239.65% | 10.96% | 6.09% | 67.88% | 52.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -186.38% | -189.82% | 60.72% | 95.66% | 223.05% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 73.29% | -1,071.43% | 3,304.39% | -36,153.85% | 53.45% |
| Cash from Investing | -414.69% | -19.88% | 44.93% | 86.48% | 123.36% |
| Total Debt Issued | 100.00% | -- | -- | -90.75% | -1,412.63% |
| Total Debt Repaid | -412.52% | 39.31% | -358.32% | -10.37% | 51.55% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.99% | -- | -- | -- | -1,171.01% |
| Cash from Financing | 6.36% | 12.96% | 3.36% | -98.90% | -146.70% |
| Foreign Exchange rate Adjustments | 108.92% | -115.81% | 1,912.71% | 267.10% | -422.77% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -91.26% | 99.30% | 1,729.17% | 19.17% | 115.85% |